Search clinical trials for: Alpha-s1 casein hydrolysate

Total 8610 results

BUZZZ Pharmaceuticals Limited
Veristat, Inc.

Completed

Efficacy and Safety of G001 in Patients With Osteoarthritis (OA) of the Knee

Osteoarthritis, Knee

Canada
Schön Klinik Berchtesgadener Land

Unknown

Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients

Chronic Obstructive Pulmonary Disease | Alpha 1-Antitrypsin Deficiency

Germany
Inland Norway University of Applied Sciences

Active, not recruiting

Alpha and Omega of Lifestyle Therapy (Alpha&Omega)

Obesity

Norway
Heidelberg University

Terminated

Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency

Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)

Germany
FORUM Pharmaceuticals Inc
Syneos Health

Completed

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Schizophrenia | Impaired Cognition

United States, Ukraine, United Kingdom, Germany, Spain, Argentina, Canada, Singapore, Russian Federation, Italy, Mexico, Colombia, Australia, Belgium, Poland, Romania
FORUM Pharmaceuticals Inc
Syneos Health; NeuroCog Trials, Inc.

Completed

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Schizophrenia | Impaired Cognition

United States, Ukraine, United Kingdom, Poland, Romania, Russian Federation, Italy, Mexico, Colombia, Argentina, Australia, Brazil
Chiesi Farmaceutici S.p.A.

Not yet recruiting

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3 (LAMPO(0-3))

Alpha-Mannosidosis
Cyprus Institute of Neurology and Genetics

Recruiting

Study of the Role of Genetic Modifiers in Hemoglobinopathies (INHERENT)

Sickle Cell Disease | Hemoglobinopathies | Thalassemia Alpha | Thalassemia, Beta

United States, Denmark, Spain, Belgium, Portugal, Congo, The Democratic Republic of the, Greece, Argentina, Brunei Darussalam, Cyprus, Israel, Italy, Nigeria, Malaysia, Angola, Pakistan
Chiesi Farmaceutici S.p.A.

Available

Expanded Access to Velmanase Alfa

Alpha-Mannosidosis
Chiesi Farmaceutici S.p.A.
Cromsource

Completed

Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis (rhLaman-08)

Alpha-Mannosidosis

France, Denmark, Austria, Germany, Italy
Chiesi Farmaceutici S.p.A.

Withdrawn

Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis (SHAMAN)

Alpha-Mannosidosis
Universidade Federal do Rio de Janeiro

Unknown

99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity

Arthritis | Psoriatic Arthritis

Brazil
Wroclaw Medical University

Unknown

The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases. (OMEGA)

Cardiovascular Diseases | Preventive Medicine | Fatty Acids | Anti-Inflammatory Agents | Eicosapentaenoic Acid | Preventive Health Services | Alpha-Linolenic Acid | Docosahexaenoic Acids

Poland
Alpha Omega Engineering Ltd.
University of Colorado, Denver; Hadassah Medical Organization; Swedish Medical...

Completed

Validation of HaGuide Software Module Accuracy in Mapping STN Boundaries in Parkinson's Disease Patients Who Underwent DBS Procedure

Parkinson Disease | Deep Brain Stimulation
Zhejiang Provincial People's Hospital

Terminated

Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer

Pancreatic Cancer | Neoadjuvant Chemotherapy

China
University Hospital, Rouen

Unknown

Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease (MyFABT1)

Anderson-Fabry Disease

France
ViaCyte
California Institute for Regenerative Medicine (CIRM); Horizon 2020 - European...

Completed

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Type 1 Diabetes Mellitus With Hypoglycemia

United States, Canada, Belgium
K2M, Inc.

Terminated

Comparison of Complication Rates Between Lateral Approaches to the Lumbar Spine (RAVINE)

Degenerative Disc Disease | Grade 1 Spondylolisthesis
University of Sulaimani

Recruiting

Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. (TNF-alpha)

Rheumatoid Arthritis | Inflammatory Arthritis | Ankylosing Spondylitis

Iraq
Impatients N.V. trading as myTomorrows
Kamada, Ltd.

No longer available

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Alpha 1-Antitrypsin Deficiency | Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Steroid Refractory Acute Graft Versus Host Disease | Alpha-1 Proteinase Inhibitor | Alpha-1 Protease Inhibitor Deficiency | Acute Graft-Versus-Host Reaction Following Bone Marrow...
Ajman University
A B Shetty Memorial Institute of Dental Science

Completed

Non-invasive Assessment of Inflammatory Markers MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and Stage 4 Periodontitis Patients

Myocardial Infarction | Periodontal Diseases

India
Children's Hospital of Philadelphia

Recruiting

Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

Lymphoma | Leukemia | Myelodysplasia

United States
Istituto Superiore di Osteopatia di Milano

Completed

The Effect of CV4 and Sacral Technique on the Alpha Bands Power

Healthy | Osteopathic Manipulation

Italy
Damanhour University

Completed

Alpha-Lipoic Acid in Breast Cancer Patients

Breast Cancer | Chemotherapeutic Toxicity

Egypt
Poitiers University Hospital

Completed

Evaluation of the Efficacy of Tamsulosin (Alpha Blockers) Compared to Phloroglucinol in Improving JJ Ureteral Stent Tolerance. A Randomized Controlled Trial

Non-oncological Indication to Ureteral Stenting

France
sigma-tau i.f.r. S.p.A.

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Malignant Melanoma

France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
Schön Klinik Berchtesgadener Land
Grifols Therapeutics LLC; Alpha-1 Foundation

Completed

Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients

Chronic Obstructive Pulmonary Disease | Alpha-1-antitrypsin-deficiency

Germany
Boston VA Research Institute, Inc.
VA Boston Healthcare System; Vielight Inc.

Recruiting

Photobiomodulation to Improve Cognition in TBI, With fMRI

Cognitive Dysfunction | Traumatic Brain Injury | Closed Head Injury

United States
Wave Life Sciences Ltd.

Recruiting

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD (RestorAATion-2)

Alpha-1 Antitrypsin Deficiency

Canada
Wave Life Sciences Ltd.

Recruiting

A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) (RestorAATion-1)

Alpha-1 Antitrypsin Deficiency

United Kingdom
CSL Behring

Active, not recruiting

Respreeza® Self-administration and Learning Program (AmAREtTI Study) (AmAREtTI)

Alpha-1 Antitrypsin Deficiency

France
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Completed

Study of DCR-A1AT in Healthy Adult Volunteers

Alpha 1-Antitrypsin Deficiency

New Zealand, Sweden
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Alpha 1-Antitrypsin Deficiency
Baxalta now part of Shire

Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

Alpha 1-Antitrypsin Deficiency

New Zealand, Australia
Baxalta now part of Shire
Baxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)

Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Alpha 1-Antitrypsin Deficiency

Australia, New Zealand
National Jewish Health
Medical University of South Carolina

Unknown

Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency (AATD_Epi)

Alpha 1-Antitrypsin Deficiency

United States
Biocerna LLC

Completed

The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency

Alpha 1-Antitrypsin Deficiency

United States
Grifols Therapeutics LLC

Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults (ChAMP)

Alpha 1-Antitrypsin Deficiency

United States
Grifols Therapeutics LLC

Completed

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency (STAMP)

Alpha 1-Antitrypsin Deficiency

United States, United Kingdom
University of Florida
Alpha-1 Foundation; Brantly, Mark L., M.D.

Completed

4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

Alpha 1-Antitrypsin Deficiency

United States
National Center for Research Resources (NCRR)
University of Pittsburgh

Terminated

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Alpha 1-Antitrypsin Deficiency

United States
Immutep Australia Pty. Ltd.

Completed

Phase 1 Study of IMP321 (Eftilagimod Alpha) Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma (TACTI-mel)

Stage IV Melanoma | Stage III Melanoma

Australia
Cure CMD

Recruiting

Congenital Muscle Disease Study of Patient and Family Reported Medical Information (CMDPROS)

Emery-Dreifuss Muscular Dystrophy | Congenital Myasthenic Syndrome | Limb-Girdle Muscular Dystrophy | Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency | Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy) and other conditions

United States
Fudan University

Terminated

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

China
Lo.Li.Pharma s.r.l

Completed

Improved Effects of MI Plus Alpha-LA in PCOS

Polycystic Ovary Syndrome

Italy
Wageningen University

Active, not recruiting

Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort)

Cardiovascular Diseases | Mortality | Type 2 Diabetes Mellitus | Cognitive Decline | Mental Well-being | Kidney Function

Netherlands
Fujian Cancer Hospital

Recruiting

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy Gastrict Cancer

China
Fatih Sultan Mehmet Training and Research Hospital

Recruiting

Comparisons of Two Different Type Heater in Different Inhalation Anesthesia in Terms of Prevention of Hypothermia

Hypothermia | Anesthesia | Heat

Turkey
Beam Therapeutics Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Alpha 1-Antitrypsin Deficiency

United Kingdom
Vertex Pharmaceuticals Incorporated

Active, not recruiting

A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype

Alpha-1 Antitrypsin Deficiency

United States, United Kingdom, Germany, Ireland

Search clinical trials for: Alpha-s1 casein hydrolysate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations